Rating History for Rhythm Pharmaceuticals (RYTM) by JPMorgan
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/27/2026 | Priyanka Grover | New Coverage | Overweight (N/A) |
145.00 (N/A) |
102.66 (106.13) |
3.38% | Details |
